The programmed cell death-1 (PD-1)/programmed death-ligand 1 (PD-L1) pathway regulates T-cell activation and function and controls the induction and maintenance of cell-based immune tolerance within the tumor microenvironment. This evidence concerns the gene CD274 and neoplasm.